mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.2 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |